Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US drug approvals quicker but fewer in 2005-07

This article was originally published in SRA

Executive Summary

The time taken to steer a drug through clinical trials and Food and Drug Administration approval in the US dropped to an average of 7.2 years in 2005-07, the lowest level since the 7.1-year average recorded in 1999-2001. At the same time, though, the number of new chemical entities approved in the US dropped by 56% from a peak of 110 in 1996-98 to just 48 in 2005-07.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS114175

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel